Medtronic’s portfolio includes numerous market-leading commercialized medical devices across cardiovascular, neurological, diabetes care, respiratory monitoring and minimally invasive surgery. Its innovations have set standards in cardiac pacing/defibrillation and expanded into many therapeutic areas with strong clinical outcomes.
Implantable electronic devices (e.g., pacemakers, defibrillators)Neurostimulation systems (e.g., deep brain stimulators)Insulin pumps and diabetes management systemsMinimally invasive surgical toolsPatient monitoring equipmentAblation systemsEndoscopy platforms
Industry
Therapeutic Medical Devices
02
Partnerships
Numerous partnerships with hospitals/surgical centers worldwideCollaborations with academic institutions for R&DStrategic alliances with technology companies for digital health solutions
03
Financials
Market cap
$134.1B
Total revenue
$36.4B
Enterprise value
$153.5B
Beyond the preview
Go deeper on Medtronic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
Trial phase
Status
Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners
Deal terms
Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
Funding rounds
Investors
Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
Peer companies
Targets
Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
Platforms
Patents
Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
Company news
Sources
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medtronic.